Zongyuan Hong (Zhe Hong)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Epithelial Mesenchymal Transition

Endoplasmic Reticulum Stress

Prostate Cancer

Top Venues

Technology in cancer research & treatment

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Junhong Li, Zongyuan Hong, Junyu Zhang, Shengfeng Zheng, Fangning Wan, Zheng Liu, Bo Dai
Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide. Oncogene 43 (10) (2024)
Junhong Li, Zongyuan Hong, Junyu Zhang, Shengfeng Zheng, Fangning Wan, Zheng Liu, Bo Dai
Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide. Oncogene 43 (10) (2024)
Junhong Li, Zongyuan Hong, Junyu Zhang, Shengfeng Zheng, Fangning Wan, Zheng Liu, Bo Dai
Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide. Oncogene 43 (10) (2024)
Junhong Li, Zongyuan Hong, Junyu Zhang, Shengfeng Zheng, Fangning Wan, Zheng Liu, Bo Dai
Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide. Oncogene 43 (10) (2024)
Junhong Li, Zongyuan Hong, Junyu Zhang, Shengfeng Zheng, Fangning Wan, Zheng Liu, Bo Dai
Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide. Oncogene (2024)
Licheng Wang, Yicong Yao, Chengdang Xu, Xinan Wang, Denglong Wu, Zongyuan Hong
Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer. Technology in cancer research & treatment 20 (2022)
Zhe Hong, Zhendong Xiang, Pan Zhang, Qiang Wu, Chengdang Xu, Xinan Wang, Guowei Shi, Zongyuan Hong, Denglong Wu
Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide. Clinical and translational medicine 11 (7) (2022)